121 related articles for article (PubMed ID: 2501761)
1. Determinant differences between the rabbit and mouse immunoglobulin kappa enhancers impair the activity of the rabbit enhancer in mouse myeloma cells.
Akimenko MA; Ekker M; Doyen N; Biben C; Rougeon F
Nucleic Acids Res; 1989 Jun; 17(12):4745-55. PubMed ID: 2501761
[TBL] [Abstract][Full Text] [Related]
2. Comparison of mouse and rabbit Ei kappa enhancers indicates that different elements within the enhancer may mediate activation of transcription and recombination.
Coquilleau I; Cavelier P; Rougeon F; Goodhardt M
J Immunol; 2000 Jan; 164(2):795-804. PubMed ID: 10623825
[TBL] [Abstract][Full Text] [Related]
3. The importance of the 3'-enhancer region in immunoglobulin kappa gene expression.
Meyer KB; Sharpe MJ; Surani MA; Neuberger MS
Nucleic Acids Res; 1990 Oct; 18(19):5609-15. PubMed ID: 2120679
[TBL] [Abstract][Full Text] [Related]
4. Identification of enhancer sequences 3' of the rabbit Ig kappa L chain loci.
Hole NJ; Harindranath N; Young-Cooper GO; Garcia R; Mage RG
J Immunol; 1991 Jun; 146(12):4377-84. PubMed ID: 1904082
[TBL] [Abstract][Full Text] [Related]
5. Activation of the immunoglobulin kappa 3' enhancer in pre-B cells correlates with the suppression of a nuclear factor binding to a sequence flanking the active core.
Meyer KB; Ireland J
Nucleic Acids Res; 1994 May; 22(9):1576-82. PubMed ID: 8202357
[TBL] [Abstract][Full Text] [Related]
6. Identification of an octamer-binding site in the mouse kappa light-chain immunoglobulin enhancer.
Currie RA; Roeder RG
Mol Cell Biol; 1989 Oct; 9(10):4239-47. PubMed ID: 2511430
[TBL] [Abstract][Full Text] [Related]
7. Organization of the transcription factor binding sites in the kappa Ig intron enhancer. Effects of position, orientation, and spacing.
Schanke JT; Van Ness BG
J Immunol; 1994 Nov; 153(10):4565-72. PubMed ID: 7963528
[TBL] [Abstract][Full Text] [Related]
8. Selective synergy of immunoglobulin enhancer elements in B-cell development: a characteristic of kappa light chain enhancers, but not heavy chain enhancers.
Fulton R; van Ness B
Nucleic Acids Res; 1994 Oct; 22(20):4216-23. PubMed ID: 7937148
[TBL] [Abstract][Full Text] [Related]
9. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.
Park K; Atchison ML
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9804-8. PubMed ID: 1946405
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors.
Pongubala JM; Atchison ML
Mol Cell Biol; 1991 Feb; 11(2):1040-7. PubMed ID: 1899281
[TBL] [Abstract][Full Text] [Related]
11. A conserved sequence in the immunoglobulin J kappa-C kappa intron: possible enhancer element.
Emorine L; Kuehl M; Weir L; Leder P; Max EE
Nature; 1983 Aug 4-10; 304(5925):447-9. PubMed ID: 6308460
[TBL] [Abstract][Full Text] [Related]
12. Identification of a second inducible DNA-protein interaction in the kappa immunoglobulin enhancer.
Nelms K; Hromas R; Van Ness B
Nucleic Acids Res; 1990 Feb; 18(4):1037-43. PubMed ID: 2107525
[TBL] [Abstract][Full Text] [Related]
13. The role of the kappa enhancer and its binding factor NF-kappa B in the developmental regulation of kappa gene transcription.
Atchison ML; Perry RP
Cell; 1987 Jan; 48(1):121-8. PubMed ID: 3098435
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin kappa gene expression after stable integration. I. Role of the intronic MAR and enhancer in plasmacytoma cells.
Blasquez VC; Xu M; Moses SC; Garrard WT
J Biol Chem; 1989 Dec; 264(35):21183-9. PubMed ID: 2512290
[TBL] [Abstract][Full Text] [Related]
15. Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region.
Betz AG; Milstein C; González-Fernández A; Pannell R; Larson T; Neuberger MS
Cell; 1994 Apr; 77(2):239-48. PubMed ID: 8168132
[TBL] [Abstract][Full Text] [Related]
16. Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility.
Lenardo M; Pierce JW; Baltimore D
Science; 1987 Jun; 236(4808):1573-7. PubMed ID: 3109035
[TBL] [Abstract][Full Text] [Related]
17. Abnormal kappa B-binding protein in the cytoplasm of a plasmacytoma cell line that lacks nuclear expression of NF-kappa B.
Liu J; Sen R; Rothstein TL
Mol Immunol; 1993 Apr; 30(5):479-89. PubMed ID: 8464429
[TBL] [Abstract][Full Text] [Related]
18. Multiple nuclear factors interact with the immunoglobulin enhancer sequences.
Sen R; Baltimore D
Cell; 1986 Aug; 46(5):705-16. PubMed ID: 3091258
[TBL] [Abstract][Full Text] [Related]
19. A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer.
Roque MC; Smith PA; Blasquez VC
Mol Cell Biol; 1996 Jun; 16(6):3138-55. PubMed ID: 8649425
[TBL] [Abstract][Full Text] [Related]
20. A human-mouse chimeric immunoglobulin gene with a human variable region is expressed in mouse myeloma cells.
Tan LK; Oi VT; Morrison SL
J Immunol; 1985 Nov; 135(5):3564-7. PubMed ID: 3930609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
